Cancer News and Research

Latest Cancer News and Research

Bariatric surgery reduces risk of heart attack, stroke or death

Bariatric surgery can cut the incidence of heart attack, stroke or death by as much as 50 percent, according to a new study presented here at the 28th Annual Meeting of the American Society for Metabolic & Bariatric Surgery.

15 Jun 2011

Change in diet can reduce cancer risk

Eating a low-carbohydrate, high-protein diet may reduce the risk of cancer and slow the growth of tumors already present, according to a study published in Cancer Research, a journal of the American Association for Cancer Research.

15 Jun 2011

VARI researchers discover protein linked to spread of head and neck cancer nasopharyngeal carcinoma

In a study recently published in Cancer Research, Van Andel Research Institute (VARI) researchers found a protein that could help predict the spread of the head and neck cancer nasopharyngeal carcinoma (NPC); this protein could also serve as part of a treatment strategy to stop the spread of the disease.

15 Jun 2011

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

Cancer diagnostics company Biomoda, Inc. received Notice of Allowance for a U.S. Patent issued today that expands on use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.

15 Jun 2011

Ventana Medical receives FDA approval for new breast cancer genetic test

The U.S. Food and Drug Administration today approved a new genetic test that will help health care professionals determine if women with breast cancer are HER2-positive and, therefore, candidates for Herceptin, a commonly used breast cancer treatment.

15 Jun 2011

Interventions can buffer caregivers from stresses faced in providing care to terminally ill patients

Interventions can buffer caregivers of terminally ill patients from the significant stresses they face in providing care to a loved one, a new evidence review finds.

15 Jun 2011

Penn State receives NIH grant to improve public health

The National Institutes of Health (NIH) has awarded Penn State, Penn State Milton S. Hershey Medical Center, and Penn State College of Medicine a $27.3 million, five-year grant designed to accelerate the translation of scientific discovery into methods for improving public health.

15 Jun 2011

Congress cuts critical funding for prostate cancer research

Congress is poised to ruin Father's Day for millions of men and their families by drastically cutting funding for prostate cancer research. Today, the House Appropriations Committee approved a bill that would provide $64 million in FY2012 for the Prostate Cancer Research Program as part of the Department of Defense's Congressionally Directed Medical Research Program.

15 Jun 2011

FDA's new sunscreen regulations will help reduce skin cancer risk

The American Academy of Dermatology Association (Academy) today said that the U.S. Food and Drug Administration's (FDA) new sunscreen regulations will help Americans reduce their risk for skin cancer by guiding them to the most effective sunscreens and advising them on other sun-protection measures.

15 Jun 2011

Research reveals how humans of different ancestry process polyunsaturated fat

Over the past decade, much progress has been made regarding the understanding and promise of personalized medicine. Scientists are just beginning to consider the impact of gene-diet interactions in different populations in regards to disease prevention and treatment.

15 Jun 2011

AJ, ATCC sign worldwide non-exclusive licensing agreement for iPS cell patent portfolio

ATCC, the premier biological materials resource and standards organization, and iPS Academia Japan, Inc. (Kyoto, Japan) (AJ) today announced a worldwide non-exclusive licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.

15 Jun 2011

Akela reports total consolidated revenues of $4.2 million for three months ended March 31, 2011

Akela Pharma, Inc., a drug development company with its lead product, Fentanyl TAIFUN, being developed for the treatment of breakthrough cancer pain and the company's wholly owned subsidiary, PharmaForm, a leading specialty contract service provider in the area of pharmaceutical dosage form development and manufacturing, today announced its financial results for the three months and year ended March 31, 2011.

15 Jun 2011

New FDA rules for sunscreen labels

The U.S. Food and Drug Administration this Tuesday released new rules that specify sunscreens’ labeling. The rules specify which lotions protect the skin and which do not.

15 Jun 2011

Flip-flops and baseball caps could pose a hidden health risk from skin cancer

Cheap, convenient and casual, baseball caps and flip-flops have a trendy charm. Those qualities make them must-wear accessories for teens, outdoor enthusiasts, gardeners or anyone trying to keep cool during the sweltering days of summer.

15 Jun 2011

Bayer's submission of IND for BAY 94-9343 triggers $2M milestone payment to ImmunoGen

ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that Bayer HealthCare Pharmaceuticals' submission of an Investigational New Drug (IND) application for the TAP compound, BAY 94-9343, triggers a $2 million milestone payment to ImmunoGen.

15 Jun 2011

Study links cysteine with obesity-related diseases

People with high levels of the amino acid cysteine carry 6-10 kilograms more fat than other people. Norwegian researchers studying this phenomenon are generating knowledge which could help to prevent and treat life-threatening obesity.

15 Jun 2011

New ultrasound technique can measure blood pressure at many points in the body

Researchers at Eindhoven University of Technology, together with the Italian company Esaote, have developed a new technique to measure the blood pressure.

15 Jun 2011

Researchers investigate the role of PlGF in mice with chronic myeloid leukemia

Chronic myeloid leukemia (CML) is a particular form of leukemia or cancer of the bone marrow, which can be treated with targeted imatinib. However, in some cases this medicine has no effect. Researchers at the VIB Vesalius Research Centre, K.U. Leuven, under the direction of Peter Carmeliet, have investigated the role of placental growth factor (PlGF) in mice with CML.

14 Jun 2011

Scientists discover Sonic Hedgehog protein's mechanism of action

A scientific breakthrough by researchers at the Institut de recherches cliniques de Montréal (IRCM) will be published tomorrow in Developmental Cell, a scientific journal of the Cell Press group. Led by Dr. Frédéric Charron, the team of scientists discovered a new requirement for the proper functioning of the Sonic Hedgehog protein.

14 Jun 2011

Humira defect lawyers file suit against Abbott Laboratories in federal court

Humira defect lawyers filed a lawsuit against Abbott Laboratories in federal court today claiming Abbott's blockbuster drug, Humira, caused a fungal infection resulting in the near-death of a Tennessee man.

14 Jun 2011